Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses
Journal of Veterinary Internal Medicine · 2025
DOI: 10.1111/jvim.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Miranda Dosi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Scotland Rural College, Edinburgh, UK. Hauptthemen laut MEDLINE: Horse Diseases, Hyperinsulinism, Insulin, Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Hyperinsulinaemia (HI) is an important feature of Equine Metabolic Syndrome (EMS). It has been suggested that reduced hepatic clearance of insulin contributes to HI, particularly in humans affected by metabolic dysfunction-associated steatotic liver disease (MASLD). Hypothesis In obese horses with HI, insulin clearance is impaired and associated with MASLD. Animals Tissue samples were collected at post-mortem from clinically well-characterized horses with HI (n = 13; basal insulin > 20 mIU/l) and without HI (control; n = 20).
Methods
Retrospective observational study. Molecular drivers of hepatic clearance (CAECAM-1, an insulin chaperone protein and IDE-Insulin Degrading Enzyme) were quantified by RT-qPCR and activity, respectively, in liver tissue. Fixed liver sections stained with hematoxylin and eosin (H&E) were assigned a histological score by two blinded observers using an equine liver disease score and a human MASLD score. Triglyceride (TG) content in liver sections, serum liver enzymes, ACTH, basal insulin, and serum triglycerides were also measured.
Results
IDE activity was 2.73 (IQR 4.00 activity/mg of protein) in HI horses and 2.18 (IQR 0.55) in controls (p = 0.07). IDE activity correlated negatively with insulin (rho = 0.561, p = 0.04) but not with liver or serum TG. CEACAM-1 gene expression was higher in the HI group (2.09 ± 1.79 folds) than in controls (0.69 ± 0.62, p = 0.03). Liver disease and MASLD scores were no different between groups, whereas triglyceride liver content was higher in horses with HI (504.83 IQR 217.51 nmol/g) compared to controls (363.58 IQR 67.32 nmol/g, p = 0.04). Conclusions and Clinical Relevance MASLD is not consistently present in HI horses, but CAECAM-1 expression is higher.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scotland Rural College, Edinburgh, UK.
- Royal (Dick) School of Veterinary Studies and Roslin Institute, University of Edinburgh, Roslin, UK.
ORCID-Profile: Miranda Dosi, Alexandra Malbon, Ruth Morgan
Zitieren
APA
Dosi, M., Scott, L., Payne, H., Poldy, J., Keen, J., McGorum, B., Malbon, A., & Morgan, R. (2025). Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70143
Vancouver
Dosi M, Scott L, Payne H, Poldy J, Keen J, McGorum B, et al. Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70143
BibTeX
@article{Dosi2025,
author = {Dosi, Miranda and Scott, Laura and Payne, Holly and Poldy, Jacqueline and Keen, John and McGorum, Bruce and Malbon, Alexandra and Morgan, Ruth},
title = {Markers of Hepatic Insulin Clearance and Their Association With Steatosis in Hyperinsulinaemic Horses},
journal = {Journal of Veterinary Internal Medicine},
year = {2025},
doi = {10.1111/jvim.70143}
}
EUVIMED